Volume 30, Issue 139 (March & April 2022)                   J Adv Med Biomed Res 2022, 30(139): 154-161 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Esmaeil Zadeh M R, Sharifi Yazdi M K, Rajabi Z, Amin Harati F, Nikkhahi F, Sharifi Yazdi S, et al . Evaluation of Specific Bacteriophage Against Salmonella infantis and Its Antibacterial Effects Compared to Ciprofloxacin in In Vitro Conditions. J Adv Med Biomed Res 2022; 30 (139) :154-161
URL: http://journal.zums.ac.ir/article-1-6281-en.html
1- Dept. of Pathobiology, Faculty of Public Health, Tehran University of Medical Sciences, Tehran, Iran
2- Zoonosis Research Center, Tehran University of Medical Sciences, Tehran, Iran
3- Food Microbiology Research Center, Tehran University of Medical Sciences, Tehran, Iran
4- Medical Student, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran
5- Center for Research of Endemic Parasites of Iran, Tehran University of Medical Sciences, Tehran, Iran
6- Dept. of Medical Laboratory Sciences, Faculty of Allied Medical Sciences, Tehran University of Medical Sciences, Tehran, Iran
7- Dept. of Pathobiology, Faculty of Public Health, Tehran University of Medical Sciences, Tehran, Iran , msoltandallal@gmail.com
Abstract:   (92687 Views)

Background and Objective: Phage therapy could be used as an alternative method to antibiotic treatments. The purpose of this study was to evaluate the antibacterial activities of isolated lytic bacteriophage against ciprofloxacin-resistant strain of Salmonella infanits in vitro conditions.
Materials and Methods: The standard strain of Salmonella infantis  and its specific bacteriophage was isolated by soft agar method. Phage susceptibility to heat and pH was evaluated by the Double-Layer Agar method.  In vitro assay was carried out on human epithelial type 2 (HEp-2) cells to investigate the effect of bacteriophage on the cytotoxic and invasion of Salmonella infantis to human epithelial cells.
Results: Head and tail morphology of bacteriophages against Salmonella infantis were identified by transmission electron microscopy and assigned to the Myoviridae family. The results of the double-layer agar assay showed that the titer of bacteriophages was 1.8×107 PFU/ml. bacteriophage was stable at 4 ֯C and the best quantification of bacteriophage was determined at pH=8. The isolated bacteriophage was specific for Salmonella infantis and had no lytic activity against other pathogenic bacteria. In the evaluation of the binding and invasion of Salmonella infantis to the HEp-2 cell line, as expected, the lytic activity of specific bacteriophage was observed following inoculation.
Conclusion: Additional studies are needed for better understanding of the interaction between phage, microorganisms and human host before applying phage therapy on a large scale.

Full-Text [PDF 1091 kb]   (47348 Downloads) |   |   Full-Text (HTML)  (1479 Views)  

 Additional studies are needed for better understanding of the interaction between phage, microorganisms and human host before applying phage therapy on a large scale.


Type of Study: Original Article | Subject: Medical Biology
Received: 2020/11/1 | Accepted: 2021/03/14 | Published: 2022/01/31

References
1. Van Hoorebeke S, Van Immerseel F, Haesebrouck F, Ducatelle R,Dewulf J. The influence of the housing system on Salmonella infections in laying hens: a review. Zoonoses Public Hlth. 2011;58:304-11. [DOI:10.1111/j.1863-2378.2010.01372.x] [PMID]
2. Gast RK, Guraya R, Jones DR, Anderson KE. Persistence of fecal shedding of Salmonella Enteritidis by experimentally infected laying hens housed in conventional or enriched cages. Poult Sci. 2015;94(7):1650-6. [DOI:10.3382/ps/pev113] [PMID]
3. Jajere SM. A review of Salmonella enterica with particular focus on the pathogenicity and virulence factors, host specificity and antimicrobial resistance including multidrug resistance. Vet World. 2019; 12(4): 504-521. [DOI:10.14202/vetworld.2019.504-521] [PMID] [PMCID]
4. Kalaba V , Golić B , Sladojević Z, Kalaba D. Incidence of Salmonella Infantis in poultry meat and products and the resistance of isolates to antimicrobials. IOP Conf. Series: Earth Environ Sci. 2017; 85:012082. [DOI:10.1088/1755-1315/85/1/012082]
5. Foley SL, Lynne AM. Food animal-associated Salmonella challenges: pathogenicity and antimicrobial resistance. J Anim Sci. 2008 Apr;86(14 Suppl):E173-87. [DOI:10.2527/jas.2007-0447] [PMID]
6. Principi N, Silvestri E, Esposito S. Advantages and limitations of bacteriophages for the treatment of bacterial infections. Front Pharmacol. 2019; 10: 513. [DOI:10.3389/fphar.2019.00513] [PMID] [PMCID]
7. Chanishvili N. Phage therapy--history from Twort and d'Herelle through Soviet experience to current approaches. Adv Virus Res. 2012;83:3-40. [DOI:10.1016/B978-0-12-394438-2.00001-3] [PMID]
8. Roach DR, Debarbieux L. Phage therapy: awakening a sleeping giant. Emerg Topic Life Sci. 2017;1(1):93-103. [DOI:10.1042/ETLS20170002] [PMID] [PMCID]
9. Soltan Dallal MM, Nikkhahi F, Alimohammadi M, et al. Phage therapy as an approach to control Salmonella enterica serotype Enteritidis infection in mice. Rev Soc Bras Med Trop. 2019;52:e20190290. [DOI:10.1590/0037-8682-0290-2019] [PMID]
10. Nilsson AS. Pharmacological limitations of phage therapy. Ups J Med Sci. 2019;124(4):218-227 [DOI:10.1080/03009734.2019.1688433] [PMID] [PMCID]
11. Esmaeil Zadeh MR,Rajabi Z,Soltan Dallal MM. Comparison of antibacterial effects of lytic bacteriophage cocktail and ciprofloxacin on strains of Salmonella enterica: An in vitro Study. Razi J MedSci.2018; 25( 171):1-10.
12. Romero-Calle D, Guimarães Benevides R, Góes-Neto A, Billington C. Bacteriophages as alternatives to antibiotics in clinical care. Antibiotics. 2019;8(3):138. [DOI:10.3390/antibiotics8030138] [PMID] [PMCID]
13. Wong CL, Sieo CC, Tan WS, et al. Evaluation of a lytic bacteriophage, Φ st1, for biocontrol of Salmonella enterica serovar Typhimurium in chickens. Int J Food Microbiol. 2014; 172:92-101. [DOI:10.1016/j.ijfoodmicro.2013.11.034] [PMID]
14. Soltan Dallal MM, Imeni SM, Nikkhahi F, Rajabi A , Ponsa Salas S. Isolation of E. Coli bacteriophage from raw sewage and comparing its antibacterial effect with ceftriaxone antibiotic. Inter J Adv Biotechnol Res.2016;793):385-391.
15. Bruun T, Sørensen G, Forshell L, et al. An outbreak of Salmonella typhimurium infections in Denmark, Norway and Sweden, 2008. Eurosurveillance. 2009; 14:10. [DOI:10.2807/ese.14.10.19147-en]
16. Philips I, Casewell M, Cox T, et al. Does the use of antibiotics in food animals pose a risk to human health? A critical review of published data. J Antimicrob Chemother. 2004; 53(1):28-52. [DOI:10.1093/jac/dkg483] [PMID]
17. Dębski B. Supplementation of pigs diet with zinc and copper as alternative to conventional antimicrobials. Pol J Vet Sci.2016,19(4):917-924. [DOI:10.1515/pjvs-2016-0113] [PMID]
18. Jamalludeen N, Johnson RP, Friendship R, Kropinski AM, Lingohr EJ, Gyles CL. Isolation and characterization of nine bacteriophages that lyse O149 enterotoxigenic Escherichia coli. Vet Microbiol. 2007 20; 124(1-2):47-57. [DOI:10.1016/j.vetmic.2007.03.028] [PMID]
19. Lu TK, Bowers J, Koeris MS. Advancing bacteriophage-based microbial diagnostics with synthetic biology. Trends Biotechnol. 2013;31(6):325-7. [DOI:10.1016/j.tibtech.2013.03.009] [PMID]
20. Gutiérrez D, Fernández L, Rodríguez A, García P. Role of bacteriophages in the implementation of a sustainable dairy chain. Front Microbiol. 2019 ; 22;10:12. [DOI:10.3389/fmicb.2019.00012] [PMID] [PMCID]
21. Połaska M, Sokołowska B. Bacteriophages-a new hope or a huge problem in the food industry. AIMS Microbiol. 2019;5(4):324-346. [DOI:10.3934/microbiol.2019.4.324] [PMID] [PMCID]
22. Lin DM, Koskella B, Lin HC. Phage therapy: An alternative to antibiotics in the age of multi-drug resistance. World J Gastrointest Pharmacol Ther. 2017; 8(3): 162-173. [DOI:10.4292/wjgpt.v8.i3.162] [PMID] [PMCID]
23. Vahedi A, Soltan Dallal MM, Douraghi M, et al. Isolation and identification of specific bacteriophage against enteropathogenic Escherichia coli (EPEC) and in vitro and in vivo characterization of bacteriophage. FEMS Microbiol Lett. 2018 ; 1;365(16):fny136. [DOI:10.1093/femsle/fny136] [PMID]
24. Shahin KH, Bouzari M. Bacteriophage application for biocontrolling Shigella flexneri in contaminated foods. J Food Sci Technol.2018; 55(2): 550-559. [DOI:10.1007/s13197-017-2964-2] [PMID] [PMCID]
25. Daneshgar F, Soltan Dallal MM, Hosseini F. Isolation of Yersinia enterocolitica bacteriophage from hospital wastewater. Inter J Enteric Pathogens2018;6(1): 18-21. [DOI:10.15171/ijep.2018.05]
26. Sillankorva SM1, Oliveira H, Azeredo J. Bacteriophages and their role in food safety. Int J Microbiol. 2012;2012:863945. [DOI:10.1155/2012/863945] [PMID] [PMCID]
27. Brovko LY, Anany H, Griffiths MW. Bacteriophages for detection and control of bacterial pathogens in food and food-processing environment. Adv Food Nutr Res. 2012;67:241-88. [DOI:10.1016/B978-0-12-394598-3.00006-X] [PMID]
28. Singh A, Poshtiban S, Evoy S. Recent advances in bacteriophage based biosensors for food-borne pathogen detection. Sensors (Basel). 2013;13(2):1763-86. [DOI:10.3390/s130201763] [PMID] [PMCID]
29. Rattanachaikunsopon P, Phumkhachorn P. Bacteriophage PPST1 isolated from hospital wastewater, a potential therapeutic agent against drug resistant Salmonella enterica subsp. enterica serovar Typhi. Salmonella - Distribution, Adaptation, Control Measures and Molecular Technologies.2006.pp.159-172.
30. Nikkhahi F, Soltan Dallal MM, Alimohammadi M, et al. Phage therapy: assessment of the efficacy of a bacteriophage isolated in the treatment of salmonellosis induced by Salmonella enteritidis in mice. Gastroenterol Hepatol Bed Bench.2017; 10(2): 131-136.
31. Torabi Bonab P, Soltan Dallal MM, Akbarzadeh S. Isolation and specificity of Salmonella enteritidis bacteriophage from hospital sewage sample. Razi J Med Sci.2018;25(167):1-9.
32. Patrick R, Dandekar A. More than simple parasites: the sociobiology of bacteriophages and their bacterial hosts. mBio. 2020; 11(2): e00041-20. [DOI:10.1128/mBio.00041-20] [PMID] [PMCID]

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Journal of Advances in Medical and Biomedical Research

Designed & Developed by : Yektaweb